Cargando…

Effects of dutasteride and tamsulosin on penile morphology in a rodent model

PURPOSE: To evaluate the penile morphology after the isolated and combined administration of dutasteride and tamsulosin in a rodent model. MATERIALS AND METHODS: Forty male rats were assigned into the following groups: Control group (C, receiving distilled water, n=10); Dutasteride group (D, receivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Da Silva, Marcello H. A., Costa, Waldemar S., Sampaio, Francisco J. B., de Souza, Diogo B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335897/ https://www.ncbi.nlm.nih.gov/pubmed/37115177 http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.0583

Ejemplares similares

The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model
por: Da Silva, Marcello H A, et al.
Publicado: (2018)

The Effect of Tamsulosin, Dutasteride Monotherapy and Tamsulosin-Dutasteride Combination on Prostate Smooth Muscle Contractility in BPH Model Wistar Strain Rattus Novergicus
por: Daryanto, Besut, et al.
Publicado: (2023)

Does treatment with dutasteride or finasteride has impact on renal morphology? Experimental study
por: da Silva, Marcello Henrique Araújo, et al.
Publicado: (2021)

Effects of comfort food diet on the penile morphology of stressed rats
por: Marchon, Roger G., et al.
Publicado: (2023)

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate
por: Miller, J, et al.
Publicado: (2009)

Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin
por: Villapalos-García, Gonzalo, et al.
Publicado: (2021)

Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
por: Zhou, Zhongbao, et al.
Publicado: (2019)

A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model
por: Udeh, Emeka I., et al.
Publicado: (2016)

Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin
por: Djavan, Bob, et al.
Publicado: (2011)

How to Quantify Penile Corpus Cavernosum Structures with Histomorphometry: Comparison of Two Methods
por: Felix-Patrício, Bruno, et al.
Publicado: (2015)

Review of dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic hyperplasia: efficacy, safety, and patient acceptability
por: Barkin, Jack
Publicado: (2011)

Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting
por: Geitona, Maria, et al.
Publicado: (2014)

Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany
por: Eisen, Christoph, et al.
Publicado: (2020)

Quercetin as a nephroprotector after warm ischemia: histomorphometric evaluation in a rodent model
por: Gonçalves, Gabriela F. Buys, et al.
Publicado: (2021)

Impact Assessment of Urethral Meatus Morphology and Penile Biometry in Transurethral Prostate and Bladder Surgery
por: Vieiralves, Rodrigo Ribeiro, et al.
Publicado: (2017)

Free combination of dutasteride plus tamsulosin for the treatment of benign prostatic hyperplasia in South Korea: analysis of drug utilization and adverse events using the National Health Insurance Review and Assessment Service database
por: Lulic, Zrinka, et al.
Publicado: (2021)

A 52‐week multicenter randomized controlled study of the efficacy and safety of add‐on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study)
por: Yamanishi, Tomonori, et al.
Publicado: (2018)

Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia
por: Saceda-Corralo, David, et al.
Publicado: (2017)

Immediate and late effects of chronic stress in the testes of prepubertal and adult rats
por: Ribeiro, Carina T, et al.
Publicado: (2018)

Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2013)

Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression
por: D’Agate, Salvatore, et al.
Publicado: (2020)

Update on the use of dutasteride in the management of benign prostatic hypertrophy
por: Miller, Joe, et al.
Publicado: (2007)

RP-HPLC Method for the Estimation of Dutasteride in Tablet Dosage Form
por: Patel, Dipti B., et al.
Publicado: (2010)

Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?
por: Proaño, Belén, et al.
Publicado: (2022)

Effects of L-Glutamine oral supplementation on prostate of irradiated rats
por: Pinto, Flavia C. M., et al.
Publicado: (2016)

Cerebral Venous Sinus Thrombosis Associated with Dutasteride Use
por: Choi, Bo Kyu, et al.
Publicado: (2020)

Characteristics of prostate biopsy in patients under the dutasteride treatment
por: Obinata, Daisuke, et al.
Publicado: (2022)

Mannitol reduces nephron loss after warm renal ischemia in a porcine model
por: Damasceno-Ferreira, José A., et al.
Publicado: (2018)

Histomorphometric comparison of the corpus cavernosum of rats submitted to euthanasia with ketamine and xylazine or isoflurane
por: Procópio, Isabella Mendes, et al.
Publicado: (2021)

Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo‐controlled study
por: Rosen, Raymond C., et al.
Publicado: (2018)

Bone Health Risks Associated with Finasteride and Dutasteride Long-Term Use
por: Sirufo, Maria Maddalena, et al.
Publicado: (2021)

The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride
por: Choi, Yong Hyeuk, et al.
Publicado: (2010)

Response of prostate cancer to addition of dutasteride after progression on abiraterone
por: Lian, Jian-Po, et al.
Publicado: (2020)

LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent
por: Luo, Dan, et al.
Publicado: (2021)

Efficacy of Tamsulosin alone versus Tamsulosin Phloroglucinol combination therapy for medical expulsion of lower Ureteral calculi
por: Shafique, Muhammad Nadeem, et al.
Publicado: (2018)

Spectrophotometric estimation of tamsulosin hydrochloride by acid-dye method
por: Shrivastava, Alankar, et al.
Publicado: (2011)

Preventive Effect of Tamsulosin on Postoperative Urinary Retention
por: Mohammadi-Fallah, Mohammadreza, et al.
Publicado: (2012)

The efficacy of tamsulosin in lower ureteral calculi
por: Griwan, M.S., et al.
Publicado: (2010)

Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
por: Fossler, Michael J., et al.
Publicado: (2015)

Effect of Improvement in Lower Urinary Tract Symptoms on Sexual Function in Men: Tamsulosin Monotherapy vs. Combination Therapy of Tamsulosin and Solifenacin
por: Ko, Kyungtae, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kbrkekt6g1d0r3uc4i9fjoncr3